Table 5.
Evidence of Strategies for Prevention of Neonatal Sepsis
| Prevention Strategy | Notes |
|---|---|
| Lactoferrin | Small studies show reduction of both fungal and bacterial infection. Large studies needed |
| IVIG | No proven efficacy for prevention of neonatal sepsis |
| Anti-staphylococcal Monoclonal Antibodies | Monoclonal antibodies against capsular polysaccharide and clumping Factor A have shown no effect in prevention of sepsis. Anti-lipoteichoic acid antibodies may have an effect but further randomized controlled studies are required. |
| Probiotics | No proven efficacy for neonatal sepsis. Useful as prevention of necrotizing enterocolitis. |
| GM-CSF/G-CSF1 | No proven efficacy of neonatal sepsis |
| Glutamine | No proven efficacy of neonatal sepsis |
| Fluconazole | Efficacious in prevention of Candida sepsis in VLBW infants |